Intellia Therapeutics, Inc. (NTLA)

Last Closing Price: 7.45 (2025-05-29)

Earnings Announcements: Estimated vs Actual

On 2025-05-08, Intellia Therapeutics, Inc. (NTLA) announced earnings per share of $-1.10 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-1.26.

The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-1.03 for the fiscal quarter ending 2025-06-30.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.

Announcement Date Fiscal Quarter End Estimated EPS Actual EPS
2025-05-08 2025-03-31 $-1.26 $-1.10
2025-02-27 2024-12-31 $-1.32 $-1.24
2024-11-07 2024-09-30 $-1.37 $-1.34
2024-08-08 2024-06-30 $-1.21 $-1.31
2024-05-09 2024-03-31 $-1.35 $-1.06
2024-02-22 2023-12-31 $-1.47 $-1.46
2023-11-09 2023-09-30 $-1.52 $-1.38
2023-08-03 2023-06-30 $-1.32 $-1.40
2023-05-04 2023-03-31 $-1.41 $-1.17
2023-02-23 2022-12-31 $-1.40 $-1.40
2022-11-03 2022-09-30 $-1.31 $-1.49
2022-08-04 2022-06-30 $-1.31 $-1.33
2022-05-05 2022-03-31 $-1.11 $-1.96
2022-02-24 2021-12-31 $-0.91 $-1.09
2021-11-04 2021-09-30 $-0.85 $-0.97
2021-08-05 2021-06-30 $-0.61 $-1.01
2021-05-06 2021-03-31 $-0.66 $-0.69
2021-02-25 2020-12-31 $-0.57 $-0.69
2020-11-05 2020-09-30 $-0.54 $-0.47
2020-08-06 2020-06-30 $-0.69 $-0.61
2020-05-07 2020-03-31 $-0.39 $-0.63
2020-02-27 2019-12-31 $-0.54 $-0.57
2019-10-31 2019-09-30 $-0.61 $-0.49
2019-08-01 2019-06-30 $-0.61 $-0.56
2019-05-02 2019-03-31 $-0.53 $-0.49
2019-02-27 2018-12-31 $-0.55 $-0.43
2018-10-31 2018-09-30 $-0.48 $-0.53
2018-08-01 2018-06-30 $-0.57 $-0.52
2018-05-01 2018-03-31 $-0.56 $-0.51
2018-03-14 2017-12-31 $-0.48 $-0.61
2017-10-31 2017-09-30 $-0.49 $-0.44
2017-08-01 2017-06-30 $-0.42 $-0.45
2017-05-02 2017-03-31 $-0.34 $-0.36
2017-03-14 2016-12-31 $-0.24 $-0.31
2016-11-01 2016-09-30 $-0.23 $-0.22
2016-08-04 2016-06-30 $-0.10 $-0.36